The combination of hyperthermia or chemotherapy with gimeracil for effective radiosensitization
- 11 February 2012
- journal article
- Published by Springer Science and Business Media LLC in Strahlentherapie und Onkologie
- Vol. 188 (3), 255-261
- https://doi.org/10.1007/s00066-011-0043-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Celecoxib steigert die Strahlenempfindlichkeit von sekundären Knochentumoren eines nicht-kleinzelligen humanen Lungenkarzinoms durch Anti-Angiogenese in vivoStrahlentherapie und Onkologie, 2010
- Gimeracil sensitizes cells to radiation via inhibition of homologous recombinationRadiotherapy and Oncology, 2010
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancerBritish Journal of Cancer, 2007
- DNA repair inhibitors in cancer treatmentClinical and Translational Oncology, 2006
- Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cellsEuropean Journal of Cancer, 2002
- Fanconi anemia cells have a normal gene structure for topoisomerase IHuman Genetics, 1994
- A Chinese hamster ovary cell line hypersensitive to ionizing radiation and deficient in repair replicationMutation Research/DNA Repair Reports, 1988
- Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.1987
- The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyureaMutation Research/DNA Repair Reports, 1984